myirislogo
21 October, 2019 07:45 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
Tata Motors 136.70 1.05
State Bank O 269.65 1.58
Tata Stl 359.90 1.19
Tata Power 60.05 0.42
Reliance 1415.30 1.37
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Indoco Remedies Limited
Indoco Remedies Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs
BSE:532612NSE:INDOCOBloomberg:INDR@INReuters:INRM.BO
Market Lot: 1Face Value: 2ISIN Demat: INE873D01024
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
28-JAN-19 The US Food and Drug Administration (USFDA) audit, which started on January 17, 2019 at Indoco's Goa Plant I (Oral Dosages Facility), concluded on January 25, 2019 with the Regulatory Agency issuing 6 observations (483s) to the site. None of these observations are critical in nature. 26-APR-18 Indoco Remedies had announced earlier about MHRA inspection at Goa Plant I from March 14, 2018 to March 16, 2018, wherein, 3 critical and 4 ma...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Indoco gets UK health regulators nod to supply critical products  -IRIS 26-Apr-18
Previous

 


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Dec-2018(9)31-Mar-2018(12)31-Mar-2017(12)
Net sales 4983.907721.4010935.10
Other Income12.1047.9038.30
Total Income4996.007769.3010973.40
Cost of goods sold-5059.107190.307670.10
OPBDIT10055.10579.003303.30
PAT-144.70411.50773.80
Gross Block---
Equity capital-184.30-
EPS (Rs.)---
DPS (Rs.)---
BV (Rs.)---
P/E range (x)---
Debt / Equity (x)---
Operating margin (% of OI)201.3 7.530.1
Net margin (% of OI)-2.9 5.3 7.1
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Indoco House
166, CST Road
Kalina
Santacruz (East)
Mumbai
Maharashtra-400 098
PHONE
(022) 2654 1851 - 55
FAX
(022) 2652 3067
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer